Buscopan Composto

Sanofi is a leading global healthcare company headquartered in Paris, France, that discovers, develops, and distributes therapeutic solutions focused on patients' needs. The company operates through several core business units, including Specialty Care, Vaccines, and Consumer Healthcare. Its Consumer Healthcare division, recently rebranded as Opella, manages a diverse portfolio of over-the-counter products, including the Buscopan range for gastrointestinal relief. Buscopan Composto is a specific combination therapy containing hyoscine butylbromide and metamizole, used to treat acute pain associated with spasms of the gastrointestinal, biliary, or genitourinary tracts. Sanofi is a publicly traded entity and maintains a significant global presence in both innovative biopharmaceuticals and established consumer brands.